doi: 10.1016/j.redox.2023.102905 152 ArthurSManoharanPSundaramSRahmanMPalaniappanBSundaramU
Ideal candidates include those with treatment-resistant depression, individuals needing quick relief from severe symptoms, or those looking for a non-oral, integrative mental health option
The company says these expanded uses underscore semaglutides growing role in addressing multiple health challenges simultaneously and make affordability a critical public health issue
For most employers, broad GLP1 coverage increases overall health care spending and raises premiums, but does provide some benefit to offset these costs
For enquiries, please email [email protected]
Obesity is a chronic, multifactorial condition and use of injectable weight-management drugs must be integrated into holistic, multidisciplinary care that prioritises overall health improvements for the individual, they concluded